ZORA Publication List
Publications
-
2023
-
2022
-
Journal Article
-
Kannan, Abhilash; Suomalainen, Maarit; Volle, Romain; Bauer, Michael; Amsler, Marco; Trinh, Hung V; Vavassori, Stefano; Pachlopnik Schmid, Jana; Vilhena, Guilherme; Marin-Gonzalez, Alberto; Pérez, Rubén; Franceschini, Andrea; von Mering, Christian; Hemmi, Silvio; Greber, Urs F (2022).
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects.
Viruses, 14(7):1407.
-
2021
-
Journal Article
-
-
Bieri, Manuela; Hendrickx, Rodinde; Bauer, Michael; Yu, Bin; Jetzer, Tania; Dreier, Birgit; Mittl, Peer R E; Sobek, Jens; Plückthun, Andreas; Greber, Urs F; Hemmi, Silvio (2021).
The RGD-binding integrins αvβ6 and αvβ8 are receptors for mouse adenovirus-1 and -3 infection.
PLoS Pathogens, 17(12):e1010083.
-
2020
-
Journal Article
-
Georgi, Fanny; Andriasyan, Vardan; Witte, Robert; Murer, Luca; Hemmi, Silvio; Yu, Lisa; Grove, Melanie; Meili, Nicole; Kuttler, Fabien; Yakimovich, Artur; Turcatti, Gerardo; Greber, Urs F (2020).
The FDA-approved drug Nelfinavir inhibits lytic cell-free, but not cell-associated non-lytic transmission of human adenovirus.
Antimicrobial Agents and Chemotherapy, 64(9):e01002-20.
-
-
2019
-
Journal Article
-
Bauer, Michael; Flatt, Justin W; Seiler, Daria; Cardel, Bettina; Emmenlauer, Mario; Boucke, Karin; Suomalainen, Maarit; Hemmi, Silvio; Greber, Urs F (2019).
The E3 Ubiquitin Ligase Mind Bomb 1 Controls Adenovirus Genome Release at the Nuclear Pore Complex.
Cell Reports, 29(12):3785-3795.e8.
-
2018
-
Journal Article
-
Stichling, Nicole; Suomalainen, Maarit; Flatt, Justin W; Schmid, Markus; Pacesa, Martin; Hemmi, Silvio; Jungraithmayr, Wolfgang; Maler, Mareike D; Freudenberg, Marina A; Plückthun, Andreas; May, Tobias; Köster, Mario; Fejer, György; Greber, Urs F (2018).
Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor.
PLoS Pathogens, 14(3):e1006914.
-
2017
-
Journal Article
-
Item, Flurin; Wueest, Stephan; Lemos, Vera; Stein, Sokrates; Lucchini, Fabrizio C; Denzler, Rémy; Fisser, Muriel C; Challa, Tenagne D; Pirinen, Eija; Kim, Youngsoo; Hemmi, Silvio; Gulbins, Erich; Gross, Atan; O'Reilly, Lorraine A; Stoffel, Markus; Auwerx, Johan; Konrad, Daniel (2017).
Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.
Nature Communications, 8:480.
-
-
-
2016
-
Journal Article
-
-
Cho, Young-Suk; Do, Manh-Hung; Kwon, Se-Young; Moon, Changjong; Kim, Kwonseop; Lee, Keesook; Lee, Sang-Jin; Hemmi, Silvio; Joo, Young-Eun; Kim, Min Soo; Jung, Chaeyong (2016).
Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers.
OncoTarget, 7(25):38210-38223.
-
Zafar, Sadia; Parviainen, Suvi; Siurala, Mikko; Hemminki, Otto; Havunen, Riikka; Tähtinen, Siri; Bramante, Simona; Vassilev, Lotta; Wang, Hongjie; Lieber, Andre; Hemmi, Silvio; de Gruijl, Tanja; Kanerva, Anna; Hemminki, Akseli (2016).
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.
OncoImmunology, 6(2):e1265717.
-
-
2015
-
Journal Article
-
Cheng, Phil F; Shakhova, Olga; Widmer, Daniel S; Eichhoff, Ossia M; Zingg, Daniel; Frommel, Sandra C; Belloni, Benedetta; Raaijmakers, Marieke I G; Goldinger, Simone M; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P (2015).
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Genome Biology, 16:42.
-
2014
-
2013
-
Journal Article
-
-
Widmer, Daniel S; Hoek, Keith S; Cheng, Phil F; Eichhoff, Ossia M; Biedermann, Thomas; Raaijmakers, Marieke I G; Hemmi, Silvio; Dummer, Reinhard; Levesque, Mitchell P (2013).
Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
Journal of Investigative Dermatology, 133(10):2436-2443.
-
2012
-
Journal Article
-
Trinh, H V; Lesage, G; Chennamparampil, V; Vollenweider, B; Burckhardt, C J; Schauer, S; Havenga, M; Greber, U F; Hemmi, S (2012).
Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection.
Journal of Virology, 86(3):1623-1637.
-
2011
-
2010
-
Journal Article
-
Hemminki, O; Bauerschmitz, G; Hemmi, S; Lavilla-Alonso, S; Diaconu, I; Guse, K; Koski, A; Desmond, R A; Lappalainen, M; Kanerva, A; Cerullo, V; Pesonen, S; Hemminki, A (2010).
Oncolytic adenovirus based on serotype 3.
Cancer Gene Therapy, 18:288-296.
-
Kälin, S; Amstutz, B; Gastaldelli, M; Wolfrum, N; Boucke, K; Havenga, M; Digennaro, F; Liska, N; Hemmi, S; Greber, U F (2010).
Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35.
Journal of Virology, 84(10):5336-5350.
-
-
2009
-
2008
-
Journal Article
-
Amstutz, B; Gastaldelli, M; Kälin, S; Imelli, N; Boucke, K; Wandeler, E; Mercer, J; Hemmi, S; Greber, U F (2008).
Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3.
The EMBO Journal, 27(7):956-969.
-
-
2007
-
Journal Article
-
Fleischli, C; Sirena, D; Lesage, G; Havenga, M J E; Cattaneo, R; Greber, U F; Hemmi, S (2007).
Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor..
Journal of General Virology, 88(11):2925-2934.
-
2006
-
Journal Article
-
Schmitz, M; Graf, C; Gut, T; Sirena, D; Peter, I; Dummer, R; Greber, U F; Hemmi, S (2006).
Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses..
Gene Therapy, 13(11):893-905.
-
2005
-
2004
-
Journal Article
-
Sirena, D; Lilienfeld, B; Eisenhut, M; Kälin, S; Boucke, K; Beerli, R R; Vogt, Lorenz; Ruedl, C; Bachmann, M F; Greber, U F; Hemmi, S (2004).
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3..
Journal of Virology, 78(9):4454-4462.
-
-
2003
-
2002
-
2001
[%=content%]
[%=content%]
[%=content%]
[%=text%]